142 related articles for article (PubMed ID: 21600126)
1. [Study of fas-mediated Foxp3+CD4+CD25+ Treg cell apoptosis in patients with systemic lupus erythematosus].
Lin XJ; Luo M; Cai XY
Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(9):586-90. PubMed ID: 21600126
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
[TBL] [Abstract][Full Text] [Related]
3. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
4. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
[TBL] [Abstract][Full Text] [Related]
5. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
[TBL] [Abstract][Full Text] [Related]
6. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE
Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
[TBL] [Abstract][Full Text] [Related]
8. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
[TBL] [Abstract][Full Text] [Related]
9. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.
Lu LY; Chu JJ; Lu PJ; Sung PK; Hsu CM; Tseng JC
J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105
[TBL] [Abstract][Full Text] [Related]
10. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
Hahn BH; Anderson M; Le E; La Cava A
Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
[TBL] [Abstract][Full Text] [Related]
11. [Studies about the level of CD4+ CD25+ regulatory T cells and relation between expression of Foxp3 and CD127 in peripheral blood of chronic HBV infection].
Deng M; Li MH; Liu SA; Liu F; Sang Y; Song SJ; Zang SF; Guan XP; Yao X; Wu XP; Cheng J; Xu DZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):21-3. PubMed ID: 20848841
[TBL] [Abstract][Full Text] [Related]
12. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
13. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids.
Azab NA; Bassyouni IH; Emad Y; Abd El-Wahab GA; Hamdy G; Mashahit MA
Clin Immunol; 2008 May; 127(2):151-7. PubMed ID: 18299252
[TBL] [Abstract][Full Text] [Related]
14. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.
Bonelli M; von Dalwigk K; Savitskaya A; Smolen JS; Scheinecker C
Ann Rheum Dis; 2008 May; 67(5):664-71. PubMed ID: 17728327
[TBL] [Abstract][Full Text] [Related]
15. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
Bonelli M; Savitskaya A; von Dalwigk K; Steiner CW; Aletaha D; Smolen JS; Scheinecker C
Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
[TBL] [Abstract][Full Text] [Related]
16. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.
Venigalla RK; Tretter T; Krienke S; Max R; Eckstein V; Blank N; Fiehn C; Ho AD; Lorenz HM
Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316
[TBL] [Abstract][Full Text] [Related]
17. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
[TBL] [Abstract][Full Text] [Related]
18. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus.
Franz B; Fritzsching B; Riehl A; Oberle N; Klemke CD; Sykora J; Quick S; Stumpf C; Hartmann M; Enk A; Ruzicka T; Krammer PH; Suri-Payer E; Kuhn A
Arthritis Rheum; 2007 Jun; 56(6):1910-20. PubMed ID: 17530636
[TBL] [Abstract][Full Text] [Related]
19. [Study of CD4+ CD25+ regulatory T cells and expression of Foxp3 mRNA in bronchiolitis and glucocorticoid regulation].
Zhu YF; Cai XH; Zhu JY; Jiang WP; Lan JH; Liu S
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1563-6. PubMed ID: 19953886
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells in patients with systemic lupus erythematosus.
Alvarado-Sánchez B; Hernández-Castro B; Portales-Pérez D; Baranda L; Layseca-Espinosa E; Abud-Mendoza C; Cubillas-Tejeda AC; González-Amaro R
J Autoimmun; 2006 Sep; 27(2):110-8. PubMed ID: 16890406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
